Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hajime Kamiya is active.

Publication


Featured researches published by Hajime Kamiya.


Expert Review of Vaccines | 2017

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

Ray Borrow; Pedro Alarcón; Josefina Carlos; Dominique A. Caugant; Hannah Christensen; Roberto Debbag; Philippe De Wals; Gabriela Echániz-Aviles; Jamie Findlow; Chris Head; Daphne Holt; Hajime Kamiya; Samir K. Saha; Sergey Sidorenko; Muhamed-Kheir Taha; Caroline L. Trotter; Julio A. Vázquez Moreno; Anne von Gottberg; Marco Aurélio Sáfadi

ABSTRACT Introduction: The 2015 Global Meningococcal Initiative (GMI) meeting discussed the global importance of meningococcal disease (MD) and its continually changing epidemiology. Areas covered: Although recent vaccination programs have been successful in reducing incidence in many countries (e.g. Neisseria meningitidis serogroup [Men]C in Brazil, MenA in the African meningitis belt), new clones have emerged, causing outbreaks (e.g. MenW in South America, MenC in Nigeria and Niger). The importance of herd protection was highlighted, emphasizing the need for high vaccination uptake among those with the highest carriage rates, as was the need for boosters to maintain individual and herd protection following decline of immune response after primary immunization. Expert commentary: The GMI Global Recommendations for Meningococcal Disease were updated to include a recommendation to enable access to whole-genome sequencing as for surveillance, guidance on strain typing to guide use of subcapsular vaccines, and recognition of the importance of advocacy and awareness campaigns.


Emerging Infectious Diseases | 2012

Transmission of Bordetella holmesii during Pertussis Outbreak, Japan

Hajime Kamiya; Nao Otsuka; Yuka Ando; Fumito Odaira; Shuji Yoshino; Kimiko Kawano; Hirokazu Takahashi; Toshihide Nishida; Yoshio Hidaka; Hiromi Toyoizumi-Ajisaka; Kazunari Kamachi; Tomimasa Sunagawa; Kiyosu Taniguchi; Nobuhiko Okabe

We describe the epidemiology of a pertussis outbreak in Japan in 2010–2011 and Bordetella holmesii transmission. Six patients were infected; 4 patients were students and a teacher at the same junior high school. Epidemiologic links were found between 5 patients. B. holmesii may have been transmitted from person to person.


Preventive Medicine | 2013

Perinatal immunization education improves immunization rates and knowledge: A randomized controlled trial

Aya Saitoh; Satoko Nagata; Akihiko Saitoh; Yuki Tsukahara; Florin Vaida; Tomoyoshi Sonobe; Hajime Kamiya; Takashi Naruse; Sachiyo Murashima

OBJECTIVES To determine if providing perinatal immunization education positively changes the immunization status of infants, influences the infant immunization knowledge, attitudes and beliefs of mothers and affects the intent to vaccinate children in Japan where immunization education is limited. METHODS Pregnant women were recruited from three sites in Tokyo, Japan and were assigned to two intervention (pre- or postnatal education) groups and a control group. The immunization status of infants was assessed and a written survey was performed before and after the intervention. RESULTS Among 119 study participants, 106 subjects replied to the post-survey. The intervention groups (34.3%) had higher immunization rates in infants at three months of age than the control group (8.3%) (P=0.005); however, no differences were observed between the prenatal (29.4%) and postnatal groups (38.9%) (P=0.40). The percentage of women intended to vaccinate their infants was higher in the intervention groups (61.4%) compared to the control group (33.3%) (P=0.01). The improvement in score for basic knowledge was higher in the intervention groups, particularly in the prenatal group (mean±S.D.: 3.4±1.8) compared to the control (1.9±1.9) (P=0.003). CONCLUSIONS Perinatal immunization education improved the immunization status of infants, increased the womens knowledge on immunization and intention to vaccinate their infants.


Morbidity and Mortality Weekly Report | 2015

Meningococcal disease among men who have sex with men - United States, January 2012-June 2015.

Hajime Kamiya; Jessica R. MacNeil; Amy Blain; Manisha Patel; Stacey W. Martin; Don Weiss; Stephanie Ngai; Ifeoma Ezeoke; Laurene Mascola; Rachel Civen; Van Ngo; Stephanie Black; Sarah Kemble; Rashmi Chugh; Elizabeth Murphy; Colette Petit; Kathleen Harriman; Kathleen Winter; Andrew J Beron; Whitney Clegg; Craig Conover; Lara K. Misegades

Since 2012, three clusters of serogroup C meningococcal disease among men who have sex with men (MSM) have been reported in the United States. During 2012, 13 cases of meningococcal disease among MSM were reported by the New York City Department of Health and Mental Hygiene (1); over a 5-month period during 2012–2013, the Los Angeles County Department of Public Health reported four cases among MSM; and during May–June 2015, the Chicago Department of Public Health reported seven cases of meningococcal disease among MSM in the greater Chicago area. MSM have not previously been considered at increased risk for meningococcal disease. Determining outbreak thresholds* for special populations of unknown size (such as MSM) can be difficult. The New York City health department declared an outbreak based on an estimated increased risk for meningococcal infection in 2012 among MSM and human immunodeficiency virus (HIV)–infected MSM compared with city residents who were not MSM or for whom MSM status was unknown (1). The Chicago Department of Public Health also declared an outbreak based on an increase in case counts and thresholds calculated using population estimates of MSM and HIV-infected MSM. Local public health response included increasing awareness among MSM, conducting contact tracing and providing chemoprophylaxis to close contacts, and offering vaccination to the population at risk (1–3). To better understand the epidemiology and burden of meningococcal disease in MSM populations in the United States and to inform recommendations, CDC analyzed data from a retrospective review of reported cases from January 2012 through June 2015.


Emerging Infectious Diseases | 2011

Pandemic (H1N1) 2009 Transmission during Presymptomatic Phase, Japan

Yoshiaki Gu; Nobuhiro Komiya; Hajime Kamiya; Yoshinori Yasui; Kiyosu Taniguchi; Nobuhiko Okabe

During an epidemiologic investigation of pandemic influenza (H1N1) 2009 virus infection in May 2009 in Osaka, Japan, we found 3 clusters in which virus transmission occurred during the presymptomatic phase. This finding has public health implications because it indicates that viral transmission in communities cannot be prevented solely by isolating symptomatic case-patients.


Vaccine | 2009

Leadership in Immunization: the relevance to Japan of the U.S.A. experience of the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP).

Hajime Kamiya; Nobuhiko Okabe

Immunization is one of the most effective public health interventions available. However, the difference of how recommendations are established influence the utilization of the vaccine and the number of patients with vaccine preventable diseases (VPDs). In this paper, we compared and highlighted the difference of the situation of the immunization program in Japan and the United States in terms of structure of policy setting system. Since the disease epidemiology clearly indicates that the US has better control of VPDs over Japan, we considered the advantage of development of a comparable vaccine policy setting system of the US in Japan.


Vaccine | 2016

Meningococcal disease in the Asia-Pacific region: Findings and recommendations from the Global Meningococcal Initiative.

Ray Borrow; Jin-Soo Lee; Julio A. Vázquez; Godwin Enwere; Muhamed-Kheir Taha; Hajime Kamiya; Hwang Min Kim; Dae Sun Jo

The Global Meningococcal Initiative (GMI) is a global expert group that includes scientists, clinicians, and public health officials with a wide range of specialties. The purpose of the Initiative is to promote the global prevention of meningococcal disease (MD) through education, research, and cooperation. The first Asia-Pacific regional meeting was held in November 2014. The GMI reviewed the epidemiology of MD, surveillance, and prevention strategies, and outbreak control practices from participating countries in the Asia-Pacific region.Although, in general, MD is underreported in this region, serogroup A disease is most prominent in low-income countries such as India and the Philippines, while Taiwan, Japan, and Korea reported disease from serogroups C, W, and Y. China has a mixed epidemiology of serogroups A, B, C, and W. Perspectives from countries outside of the region were also provided to provide insight into lessons learnt. Based on the available data and meeting discussions, a number of challenges and data gaps were identified and, as a consequence, several recommendations were formulated: strengthen surveillance; improve diagnosis, typing and case reporting; standardize case definitions; develop guidelines for outbreak management; and promote awareness of MD among healthcare professionals, public health officials, and the general public.


Epidemiology and Infection | 2013

A Shiga toxin-producing Escherichia coli O157 outbreak associated with consumption of rice cakes in 2011 in Japan.

Nabae K; Takahashi M; Wakui T; Hajime Kamiya; Nakashima K; Kiyosu Taniguchi; Nobuhiko Okabe

In May 2011, an outbreak of Shiga toxin-producing Escherichia coli (STEC) O157 was reported from Yamagata Prefecture, Japan. Investigations, including a case-control study, revealed that the outbreak was linked to two varieties of rice cakes produced by a local manufacturer between 2 and 7 May. Active and passive surveillance identified 136 suspected cases, 142 confirmed cases, 26 asymptomatic cases, and 25 secondary cases. While no environmental samples taken from the manufacturing premises tested positive for STEC, other than a stool sample taken from one employee, on-site and epidemiological investigations indicated that STEC was introduced during the manufacturing process of rice cakes rather than through contamination of raw materials. This was the first reported outbreak of STEC associated with cakes and confectionery in Japan, which indicates that contamination and outbreaks of STEC can occur in any food unless proper precautions are taken.


Western Pacific Surveillance and Response Journal | 2017

Exposure to H1 genotype measles virus at an international airport in Japan on 31 July 2016 results in a measles outbreak

Aika Watanabe; Yusuke Kobayashi; Tomoe Shimada; Yuichiro Yahata; Ayako Kobayashi; Mizue Kanai; Yushi Hachisu; Munehisa Fukusumi; Hajime Kamiya; Takuri Takahashi; Yuzo Arima; Hitomi Kinoshita; Kazuhiko Kanou; Takehito Saitoh; Satoru Arai; Hiroshi Satoh; Hideo Okuno; Saeko Morino; Tamano Matsui; Tomimasa Sunagawa; Keiko Tanaka-Taya; Makoto Takeda; Katsuhiro Komase; Kazunori Oishi

a Field Epidemiology Training Program, National Institute of Infectious Diseases. b Department of Epidemiology for Infectious Diseases, Graduate School of Medicine, Osaka University, Japan. c Infectious Disease Surveillance Center, National Institute of Infectious Diseases. d Department of Virology III, National Institute of Infectious Diseases. e Division of Global Infectious Diseases, Department of Infection and Epidemiology, Graduate School of Medicine, Tohoku University, Miyagi, Japan. Submitted: 22 December 2016; Published: 07 February 2017 doi: 10.5365/wpsar.2016.7.4.007 Exposure to H1 genotype measles virus at an international airport in Japan on 31 July 2016 results in a measles outbreak


Japanese Journal of Infectious Diseases | 2016

A Epidemiological Investigation of a Nosocomial Outbreak of Multidrug-Resistant Acinetobacter baumannii in a Critical Care Center in Japan, 2011–2012

Hiroto Ushizawa; Yuichiro Yahata; Takeo Endo; Tomoko Iwashima; Michiyo Misawa; Makoto Sonobe; Takuya Yamagishi; Hajime Kamiya; Kazutoshi Nakashima; Tamano Matsui; Mari Matsui; Satowa Suzuki; Mikio Doi; Fujiko Irie; Shinichi Yamato; Yasuhiro Otomo; Kazunori Oishi

In 2011, a multidrug-resistant Acinetobacter baumannii (MDRAB) outbreak occurred at a Japanese critical care center (CCC) in a tertiary care hospital. Multidrug-resistance in Japan is defined as resistance to the antimicrobials amikacin, carbapenem, and fluoroquinolone. We conducted a retrospective epidemiological investigation of this outbreak to identify the risk factors for MDRAB respiratory tract acquisition in this hospital. Cases were defined as hospitalized patients with MDRAB-positive cultures at least 3 days post admission to the CCC between June 1, 2011 and April 20, 2012. Fifteen MDRAB cases were identified, including 3 with infection and 12 with colonization. This case-control study demonstrated that hypoalbuminemia along with carbapenem administration were associated with MDRAB respiratory tract acquisition. Pulsed-field gel electrophoresis analysis and multilocus sequence typing using MDRAB isolates suggested a clonal dissemination of MDRAB strains with sequence type 74 occurred primarily among patients admitted to the CCC. From April 16, 2012, a decreased isolation rate of MDRAB in the hospital occurred after the implementation of the following infection control measures: closing the emergency room, discontinuing admission to the CCC, isolating patients with MDRAB colonization or infection to single room status, and conducting environmental cleaning. No MDRAB cases were detected between March 23 and April 20, 2012.

Collaboration


Dive into the Hajime Kamiya's collaboration.

Top Co-Authors

Avatar

Nobuhiko Okabe

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Tamano Matsui

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Yuichiro Yahata

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Kiyosu Taniguchi

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mizue Kanai

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yoshinori Yasui

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge